Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis

被引:96
|
作者
Jin, J-K [1 ,2 ]
Tien, P-C [1 ]
Cheng, C-J [3 ]
Song, J. H. [1 ]
Huang, C. [4 ]
Lin, S-H [1 ,2 ,5 ]
Gallick, G. E. [1 ,2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr Appl Res Genitourinary Canc, Dept Genitourinary Med Oncol, Unit 18 4, Houston, TX 77030 USA
[2] Univ Texas Houston, Grad Sch Biomed Sci, Program Canc Metastasis, Houston, TX USA
[3] Taipei Med Univ, Dept Pathol, Coll Med, Taipei, Taiwan
[4] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY USA
[5] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr Appl Res Genitourinary Canc, Dept Translat Mol Pathol, Unit 89, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
INTEGRIN EXPRESSION; BINDING; PROGRESSION; ADHESION; CARCINOMA; SUBUNIT; DOMAIN; TAILS; SITES; CELLS;
D O I
10.1038/onc.2014.116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Talins are adaptor proteins that regulate focal adhesion signaling by conjugating integrins to the cytoskeleton. Talins directly bind integrins and are essential for integrin activation. We previously showed that beta 1 integrins are activated in metastatic prostate cancer (PCa) cells, increasing PCa metastasis to lymph nodes and bone. However, how beta 1 integrins are activated in PCa cells is unknown. In this study, we identified a novel mechanism of beta 1 integrin activation. Using knockdown experiments, we first demonstrated that talin1, but not talin2, is important in beta 1 integrin activation. We next showed that talin1 S425 phosphorylation, but not total talin1 expression, correlates with metastatic potential of PCa cells. Expressing a non-phosphorylatable mutant, talin1(S425A), in talin1-silenced PC3-MM2 and C4-2B4 PCa cells, decreased activation of beta 1 integrins, integrin-mediated adhesion, motility and increased the sensitivity of the cells to anoikis. In contrast, reexpression of the phosphorylation-mimicking mutant talin1(S425D) led to increased beta 1 integrin activation and generated biologic effects opposite to talin1(S425A) expression. In the highly metastatic PC3-MM2 cells, expression of a non-phosphorylatable mutant, talin1(S425A), in talin1-silenced PC3-MM2 cells, abolished their ability to colonize in the bone following intracardiac injection, while reexpression of phosphorylation-mimicking mutant talin1(S425D) restored their ability to metastasize to bone. Immunohistochemical staining demonstrated that talin S425 phosphorylation is significantly increased in human bone metastases when compared with normal tissues, primary tumors or lymph node metastases. We further showed that p35 expression, an activator of Cdk5, and Cdk5 activity were increased in metastatic tumor cells, and that Cdk5 kinase activity is responsible for talin1 phosphorylation and subsequent beta 1 integrin activation. Together, our study reveals Cdk5-mediated phosphorylation of talin1 leading to beta 1 integrin activation is a novel mechanism that increases metastatic potential of PCa cells.
引用
收藏
页码:1811 / 1821
页数:11
相关论文
共 50 条
  • [41] A novel screening test for colon cancer: Talin-1
    Bostanci, O.
    Kemik, O.
    Kemik, A.
    Battal, M.
    Demir, U.
    Purisa, S.
    Mihmanli, M.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (17) : 2533 - 2537
  • [42] The role of metastasis-associated protein 1 (MTA1) in prostate cancer bone metastases
    Levenson, A. S.
    Wang, J.
    Chung, Y.
    Jarrett, J.
    Laskin, W. B.
    Huang, C.
    Satcher, R. L.
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 42 - 42
  • [43] Metastasis-associated protein 1 (MTA1) was highly expressed and localized in nucleus in prostate cancer bone metastasis
    Wang, J.
    Levenson, A.
    Jarret, J.
    Laskin, W.
    Satcher, R.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S293 - S293
  • [44] The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer
    Ilenia Masi
    Flavia Ottavi
    Danila Del Rio
    Valentina Caprara
    Cristina Vastarelli
    Sara Maria Giannitelli
    Giulia Fianco
    Pamela Mozetic
    Marianna Buttarelli
    Gabriella Ferrandina
    Giovanni Scambia
    Daniela Gallo
    Alberto Rainer
    Anna Bagnato
    Francesca Spadaro
    Laura Rosanò
    [J]. Cell Death & Disease, 14
  • [45] The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer
    Masi, Ilenia
    Ottavi, Flavia
    Del Rio, Danila
    Caprara, Valentina
    Vastarelli, Cristina
    Giannitelli, Sara Maria
    Fianco, Giulia
    Mozetic, Pamela
    Buttarelli, Marianna
    Ferrandina, Gabriella
    Scambia, Giovanni
    Gallo, Daniela
    Rainer, Alberto
    Bagnato, Anna
    Spadaro, Francesca
    Rosano, Laura
    [J]. CELL DEATH & DISEASE, 2023, 14 (01)
  • [46] AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer
    Zhu, Hong
    Chang, Lin-Lin
    Yan, Fang-Jie
    Hu, Yan
    Zeng, Chen-Ming
    Zhou, Tian-Yi
    Yuan, Tao
    Ying, Mei-Dan
    Cao, Ji
    He, Qiao-Jun
    Yang, Bo
    [J]. THERANOSTICS, 2018, 8 (03): : 676 - 692
  • [47] Angiotensin-(1-7) inhibits prostate cancer angiogenesis and metastasis to bone
    Krishnan, Bhavani
    Smith, Thomas L.
    Dubey, Purnima
    Zapadka, Michael E.
    Torti, Frank M.
    Tallant, E. Ann
    Gallagher, Patricia E.
    [J]. CANCER RESEARCH, 2011, 71
  • [48] α1 and β1 integrins enhance the homing and differentiation of cultured prostate cancer stem cells
    Rentala, Satyanarayana
    Yalavarthy, Prameela Devi
    Mangamoori, Lakshmi Narasu
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2010, 12 (04) : 548 - 555
  • [49] Mechanism of bone metastasis in prostate cancer: Role of anterior gradient homolog 2
    Chanda, Diptiman
    Sawant, Anandi
    Isayeva, Tatyana
    Ponnazhagan, Selvarangan
    [J]. CANCER RESEARCH, 2010, 70
  • [50] Molecular mechanism of osteoblastic bone metastasis via intercellular communication in prostate cancer
    Ito, Kagenori
    Yamamoto, Yusuke
    Nakayama, Jun
    Shimasaki, Takeo
    Urabe, Fumihiko
    Kimura, Takahiro
    Egawa, Shin
    Ochiya, Takahiro
    [J]. CANCER SCIENCE, 2022, 113 : 1575 - 1575